Zusammenfassung
Eine der Hauptstrategien bei der Entwicklung neuer Psychopharmaka während der letzten Jahre war die Suche nach neuen Substanzen mit immer spezifischeren und selektiveren molekularen Wirkungsmechanismen. Beispiele dafür sind die hochselektiven Serotonin-Wiederaufnahme-Inhibitoren aus dem Bereich der Antidepressiva, die 5-HT1A-Agonisten aus dem Bereich der Anxiolytika, oder die Suche nach hochselektiven zentral-wirksamen M1-Agonisten zur Therapie der Demenz. Im direkten Kontrast zu diesen neuen therapeutischen Ansätzen, die auf eine hochspezifische Beeinflussung nur eines selektiven Parameters im Bereich eines spezifischen Transmitter-systems abzielen, stehen zwei neuere Substanzen (S-Adenosyl-Methionin und Phosphatidylserin), die relativ unselektiv allgemeine Funktionen der Nervenzelle beeinflussen, wobei beide Substanzen möglicherweise über eine Modifikation der Eigenschaften der neuronalen Membran in zentralnervöse Funktionen eingreifen.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
Literatur
Amaducci L (1988) Phosphatidylserine in the treatment of Alzheimer’s disease: results of multi-center study. Psychopharmacol Bull 24: 130–134
Baldessarini RJ (1987) Neuropharmacology of S-Adenosyl-L-Methionine. Am J Med 83 (Supp l5A): 95–103
Calderini G, Aporti F, Bellini F et al. (1985) Phospholipids as pharmacological tools in the aging brain. In: Horrocks LA (ed) Phospholipids in the nervous system, Vol 2. Raven Press, New York, pp 11–19
Calderini G, Bellini F, Bonetti AC et al. (1987) Pharmacological properties of phosphatidylserine in the ageing brain. Clin Trials J 24: 9–17
Carney MWP (1986) Neuropharmacology of S-Adenosyl-Methionine. Clin Neuropharmacol 9: 235–243
Cimino M, Vantini G, Algeri S, Curatola G, Pezzoli C, Stramentinoli G (1984) Age-related modification of dopaminergic and β-adrenergic receptor system: Restoration to normal activity by modifying membrane fluidity with S-Adenosylmethionine. Life Sei 34: 2029–2039
Cohen BM, Satlin A, Zubenko G (1988) S-Adenosyl-L-methionine in the treatment of Alzheimer’s disease. J Clin Psychopharmacol 8: 43–47
Crook T, Tinklenberg J, Yesavage J, Petrie W, Nunzi MG, Casade Massari D (1991) Effects of phosphatidylserine in age-associated memory impairment. Neurology 41: 644–649
Denaro A, Fioravanti M, Lucarelli F, Thorel M, Parmegiani M, Agnoli A (1988) Tetrahydrofolic acid and S-adenosyl methionine in the treatment of pathological aging brain and dementia. In: Agnoli A, Cohn J, Lassen N, Mayreux L (eds) Senile dementia. II. International Symposium, John Libbey Eurotext, Paris, pp 437–443
Friedel HA, Goa KL, Benfield P (1989) S-Adenosyl-L-Methionie. A Review of its pharmacological properties and therapeutic potential in liver dysfunction and affective disorders in relation to its physiological role in cell metabolism. Drugs 38: 389–416
Janicak PG, Lipinski J, Davis JM, Altman E, Sharma P (1989) Parenteral S-adenosyl-methionine (SAMe) in depression: Literature review and preliminary data. Psychopharmacol Bull 25: 238–242
Kagan BL, Sultzer DL, Rosenlicht N, Gerner RH (1990) Oral S-Adenosylmethionine in Depression: A randomized, double-blind, placebo-controlled trial. Am J Psychiatry 147: 591–595
Müller WE, Gelbmann CM, Cohen SA, Stoll L, Schubert T, Hartmann H (1992) Age-associated changes of muscarinic cholinergic and N-methyl-D-aspartate receptors in the mouse brain. Partial reconstitution by phosphatidylserine treatment. In: Balduini C, Zwilling R (eds) Biology of aging, Springer, Berlin Heidelberg New York Tokyo (in press)
Rosenbaum JF, Fava M, Falk WE, Pollack MH, Cohen LS, Cohen BM, Zubenko GS (1990) The antidepressant potential of oral S-adenosyl-1-methionine. Acta Psychiatr Scand 81: 432–436
Vahora SA, Malek-Ahmadi P (1988) S-Adenosylmethionine in the treatment of depression. Neu-rosci Biobehav Rev 12: 139–141
Valzelli L, Kozak W, Zanotti A, Toffano G (1987) Activity of phosphatidylserine on memory retrieval and on exploration in mice. Meth Find Expl Clin Pharmacol 9: 657–660
Zanotti A, Valzelli L, Toffano G (1989) Chronic phosphatidylserine treatment improves spatial memory and passive avoidance in aged rats. Psychopharmacology 99: 316–321
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1992 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Müller, W.E. (1992). Neuronale Membran-Angriffsmechanismen am Beispiel von Phosphatidylserin und S-Adenosyl-Methionin. In: Gaebel, W., Laux, G. (eds) Biologische Psychiatrie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-77086-9_41
Download citation
DOI: https://doi.org/10.1007/978-3-642-77086-9_41
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-54784-6
Online ISBN: 978-3-642-77086-9
eBook Packages: Springer Book Archive